NHAS
ZBIO

Novo Holdings A/S’s Zenas BioPharma ZBIO Stock Holding History

Novo Holdings A/S’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,450,000
Closed -$52.6M – 25
2025
Q4 		$52.6M Sell
1,450,000
-550,000
-28% -$18.1M 4.09% 9
2025
Q3 		$44.4M Sell
2,000,000
-250,000
-11% -$4.07M 2.86% 11
2025
Q2 		$21.8M Buy
2,250,000
+35,033
+2% +$341K 1.54% 19
2025
Q1 		$17.5M Buy
2,214,967
+614,967
+38% +$4.81M 1.33% 20
2024
Q4 		$13.1M Buy
1,600,000
+450,000
+39% +$7.02M 0.79% 25
2024
Q3 		$19.5M Buy
+1,150,000
New +$20.7M 0.97% 26

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

Novo Holdings A/S's ZBIO Position: Q1 2026 in Review

Novo Holdings A/S sold out of Zenas BioPharma (ZBIO) in Q1 2026, closing a stake of 1,450,000 shares — an estimated $52.6M sold.

Novo Holdings A/S first reported a position in ZBIO in Q3 2024 and held it in 6 quarters. The position peaked at $52.6M in Q4 2025. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • Novo Holdings A/S reported no remaining Zenas BioPharma position as of Q1 2026 after selling out during the quarter.
  • Novo Holdings A/S sold 1,450,000 Zenas BioPharma shares in Q1 2026, an estimated $52.6M.
  • Novo Holdings A/S first reported a position in Zenas BioPharma in Q3 2024 and held it in 6 quarters.
  • Novo Holdings A/S's Zenas BioPharma position peaked at $52.6M in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on Novo Holdings A/S's 13F filing for Q1 2026, filed 15 May 2026.